Ocular Drug Delivery Solutions
-
NanoImprove Your Small And Large Molecule Formulations
9/24/2024
Can your product be NanoImproved? Find out at at-a-glance with a 4-page informational spread covering new molecules and reformulations, small molecules and biologics, technology details, and proof points.
-
Oral Dosage Form Development
10/23/2024
Oral administration remains the most widely used route for the successful delivery of active pharmaceuticals to patients.
-
Nasal Dosage Form Development
10/23/2024
Upperton have developed UpperNose™, a nasal product development approach designed to streamline the development process for nasal dosage forms.
-
Organ On A Chip: Advancing New Approach Methodologies
2/18/2025
Explore new approach methodologies, integrating in vitro and computational models to improve toxicology testing, and drug development, enhancing accuracy, efficiency, and human relevance.
-
Prefilled Syringe Plungers: Mitigate Against Risks To Improve Success
3/4/2025
From start to finish, NovaPure components have been designed and manufactured using Quality by Design principles to mitigate risk for the patient.
-
Streamlining The Generic Combination Device Design Assessment Process
3/19/2025
A new six-phase assessment process simplifies regulatory approval for generic drug-device combination products, reducing costs and timelines while maintaining safety, effectiveness, and substitutability with reference-listed drugs.
-
Battelle: 90 Years Of Innovation
3/19/2025
Battelle, a leading nonprofit in applied science and technology, drives innovation in national security, healthcare, environment, and education while managing research labs and advancing critical discoveries.
-
Building The CDMO Of The Future
5/2/2025
The kojoX philosophy is designed to overcome capacity constraints, regulatory complexities, and geopolitical risks to deliver unmatched scale, speed, supply chain agility, and resilience.
-
Highly Flexible And Customizable On-Body Delivery System Platform
5/27/2025
Learn how Vertiva™ can enable delivery of micro-precision basal doses and full-content bolus injections, resulting in a highly flexible, customizable platform suitable for a wide range of therapies.
-
Analytical Services
5/27/2025
As part of Stevanato Group’s commitment to R&D, our analytical testing sites focus on investigating the physico-chemical properties and interactions of primary packaging materials and drug products.